Severe hypoglycaemia, cardiovascular outcomes and death: Experience from the 'Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results' (LEADER) trial

被引：0
|
作者：
Bain, S. [1 ]
Zinman, B. [2 ]
Marso, S. P. [3 ]
Christiansen, E. [4 ]
Calanna, S. [4 ]
Rasmussen, S. [4 ]
Buse, J. B. [5 ]
机构：
[1] Univ Swansea, Sch Med, Swansea, W Glam, Wales
[2] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada
[3] Res Med Ctr, Kansas City, MO USA
[4] Novo Nordisk AS, Soborg, Denmark
[5] Univ N Carolina, Sch Med, Chapel Hill, NC USA
来源：
DIABETIC MEDICINE | 2018年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A17
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [41] Atherosclerotic Cardiovascular Events Prediction Using Machine Learning Models: Results From Action to Control Cardiovascular Risk in Diabetes Trial
    Fan, Wenjun
    CIRCULATION, 2020, 141
  • [42] Association Of Kidney And Cardiovascular Outcomes: Insights From The Empagliflozin Cardiovascular Outcome Event Trial In Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME) Trial
    Sharma, Abhinav
    Inzucchi, Silvio E.
    Testani, Jeffrey
    Ofstad, Anne-Pernille
    Fitchett, David
    Mattheus, Michaela
    Verma, Subodh
    Zannad, Faiez
    Wanner, Christoph
    Kraus, Bettina J.
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (05) : S103 - S103
  • [43] Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin
    Navar, Ann Marie
    Gallup, Dianne S.
    Lokhnygina, Yuliya
    Green, Jennifer B.
    McGuire, Darren K.
    Armstrong, Paul W.
    Buse, John B.
    Engel, Samuel S.
    Lachin, John M.
    Standl, Eberhard
    Van de Werf, Frans
    Holman, Rury R.
    Peterson, Eric D.
    HYPERTENSION, 2017, 70 (05) : 907 - +
  • [44] Cardiovascular (CV) and hypoglycaemia outcomes across age groups in people with type 2 diabetes in the CAROLINA trial
    Espeland, M. A.
    Pratley, R. E.
    Rosenstock, J.
    Kadowaki, T.
    Seino, Y.
    Zinman, B.
    Marx, N.
    McGuire, D. K.
    Andersen, K. R.
    Mattheus, M.
    Keller, A.
    Johansen, O. E.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S75 - S75
  • [45] Effect of Liraglutide on Cardiovascular Outcomes in Elderly Patients: A Post Hoc Analysis of a Randomized Controlled Trial
    Gilbert, Matthew P.
    Bain, Stephen C.
    Franek, Edward
    Jodar-Gimeno, Esteban
    Nauck, Michael A.
    Pratley, Richard
    Rea, Rosangela Roginski
    Kerr Saraiva, Jose Francisco
    Rasmussen, Soren
    Tornoe, Karen
    von Scholten, Bernt Johan
    Buse, John B.
    Nauck, Michael A.
    Bain, Stephen C.
    Pratley, Richard
    Marso, Steven
    Zinman, Bernard
    Nissen, Steven
    Poulter, Neil
    Mann, Johannes
    Baeres, Florian M. M.
    ANNALS OF INTERNAL MEDICINE, 2019, 170 (06) : 423 - +
  • [46] A higher non-severe hypoglycaemia rate is associated with an increased risk of subsequent severe hypoglycaemia and major adverse cardiovascular events in individuals with type 2 diabetes in the LEADER study
    Heller, Simon R.
    Geybels, Milan S.
    Iqbal, Ahmed
    Liu, Lei
    Wagner, Lily
    Chow, Elaine
    DIABETOLOGIA, 2022, 65 (01) : 55 - 64
  • [47] Effect of empagliflozin on cardiovascular death in subgroups by age: results from EMPA-REG OUTCOME
    Ridderstrale, M.
    Fitchett, D.
    Kis, S. Giljanovic
    Woerle, H. J.
    Mattheus, M.
    Zinman, B.
    Inzucchi, S.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1192 - 1192
  • [48] EFFECT OF EMPAGLIFLOZIN ON CARDIOVASCULAR DEATH IN SUBGROUPS BYAGE: RESULTS FROM EMPA-REG OUTCOME
    D'Emden, M.
    Fitchett, D.
    Kis, Giljanovic S.
    Woerle, H.
    Zinman, B.
    Inzucchi, S.
    NEPHROLOGY, 2016, 21 : 58 - 58
  • [49] Effect of empagliflozin on cardiovascular death in subgroups by age: results from EMPA-REG OUTCOME
    Toural, E.
    Ridderstrale, M.
    Fitchett, D.
    Kis, S. Giljanovic
    Woerle, H. -J.
    Mattheus, M.
    Zinman, B.
    Inzucchi, S. E.
    DIABETOLOGIA, 2016, 59 : S539 - S540
  • [50] Effect of Empagliflozin on Cardiovascular Death in Subgroups by Age: Results from EMPA-REG Outcome
    Ridderstrale, Martin
    Toural, Elvira
    Fitchett, David
    Kis, Sanja Giljanovic
    Woerle, Hans J.
    Mattheus, Michaela
    Zinman, Bernard
    Inzucchi, Silvio E.
    DIABETES, 2016, 65 : A289 - A290
12345